SCHEMBL13298575

SCHEMBL13298575

c1ccc([SiH2]c2ccc3c(-c4cc(-c5cccc6ccccc56)cc(-c5cccc6ccccc56)c4)c4ccccc4c(-c4cccc5ccccc45)c3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.35
▸ ACMSD Q8TDX5 1/20 0.35
▸ SOS1 Q07889 1/20 0.35
▸ DHFR P00374 1/20 0.34
▸ FNTA P49354 1/20 0.33
▸ FNTB P49356 1/20 0.33
▸ ENPP3 O14638 1/20 0.33
▸ ENPP1 P22413 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CA12 O43570 2/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ CA9 Q16790 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13298583 1.00 MCL1 (0.35) MCL1ACMSDSOS1DHFRFNTA
SCHEMBL13298542 0.93 MCL1 (0.37) MCL1ACMSDSOS1DHFRENPP3
SCHEMBL13298545 0.93 MCL1 (0.37) MCL1ACMSDSOS1DHFRENPP3
SCHEMBL13298573 0.93 CA12 (0.34) MCL1ACMSDSOS1DHFRMEN1
SCHEMBL13298569 0.93 CA12 (0.34) MCL1ACMSDSOS1DHFRMEN1
SCHEMBL13298586 0.92 SOS1 (0.37) MCL1ACMSDSOS1FNTAFNTB
SCHEMBL13298580 0.92 SOS1 (0.37) MCL1ACMSDSOS1FNTAFNTB
SCHEMBL13298502 0.92 MCL1 (0.38) MCL1ACMSDSOS1DHFRENPP3
SCHEMBL13298500 0.92 MCL1 (0.38) MCL1ACMSDSOS1DHFRENPP3
SCHEMBL13298460 0.92 THRA (0.36) MCL1ACMSDSOS1DHFRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same DONGJIN SEMICHEM CO., LTD (KR) 2010-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same TRPA1, TRPM2, TRPM4 MCL1 3996/4885ACMSD 191/4885SOS1 2366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback